Manhattan Scients
Manhattan Scientifics, Inc., a technology incubator, engages in the acquisition, development, and commercialization of life-enhancing technologies in the United States. It develops technologies in the areas of nano-technologies and nano-medicine. The company also offers nanostructured bulk metals and alloys in the form of rod, bar, wire, and foil for medical implants and other applications. The c… Read more
Manhattan Scients - Asset Resilience Ratio
Manhattan Scients (MHTX) has an Asset Resilience Ratio of 83.07% as of June 2021. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2008–2020)
This chart shows how Manhattan Scients's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Manhattan Scients's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 0% |
| Short-term Investments | $3.78 Million | 83.07% |
| Total Liquid Assets | $3.78 Million | 83.07% |
Asset Resilience Insights
- Very High Liquidity: Manhattan Scients maintains exceptional liquid asset reserves at 83.07% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Manhattan Scients Industry Peers by Asset Resilience Ratio
Compare Manhattan Scients's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Shanghai Kehua Bio-Engineering Co Ltd
SHE:002022 |
Medical Devices | 0.01% |
|
Jiangsu Yuyue Medical Equipment & Supply Co Ltd
SHE:002223 |
Medical Devices | 0.26% |
|
Double Medical Technology Inc
SHE:002901 |
Medical Devices | 7.79% |
|
Wuhan Easy Diagnosis Biomedicine Co Ltd Class A
SHE:002932 |
Medical Devices | 6.64% |
|
Shinhung
KO:004080 |
Medical Devices | 4.17% |
|
UMediC Group Berhad
KLSE:0256 |
Medical Devices | 1.48% |
|
Osang Healthcare Co.,Ltd
KQ:036220 |
Medical Devices | 9.34% |
|
HansBiomed Corporation
KQ:042520 |
Medical Devices | 9.13% |
Annual Asset Resilience Ratio for Manhattan Scients (2008–2020)
The table below shows the annual Asset Resilience Ratio data for Manhattan Scients.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2020-12-31 | 85.79% | $5.88 Million | $6.85 Million | -- |
| 2018-12-31 | 0.00% | $0.00 | $2.66 Million | -- |
| 2017-12-31 | 0.00% | $0.00 | $10.85 Million | -- |
| 2016-12-31 | 0.00% | $0.00 | $7.63 Million | -- |
| 2015-12-31 | 0.00% | $0.00 | $12.87 Million | -- |
| 2012-12-31 | 1.19% | $22.00K | $1.85 Million | -0.33pp |
| 2011-12-31 | 1.52% | $32.00K | $2.10 Million | -1.85pp |
| 2010-12-31 | 3.37% | $65.00K | $1.93 Million | -9.29pp |
| 2008-12-31 | 12.66% | $129.00K | $1.02 Million | -- |